[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IN2007CH05103A - - Google Patents

Info

Publication number
IN2007CH05103A
IN2007CH05103A IN5103CH2007A IN2007CH05103A IN 2007CH05103 A IN2007CH05103 A IN 2007CH05103A IN 5103CH2007 A IN5103CH2007 A IN 5103CH2007A IN 2007CH05103 A IN2007CH05103 A IN 2007CH05103A
Authority
IN
India
Application number
Inventor
Louis Crocker
Ian Davies
Richard OSIFCHIN
Andrew Kotliar
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22772880&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2007CH05103(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Publication of IN2007CH05103A publication Critical patent/IN2007CH05103A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IN5103CH2007 2000-05-26 2007-11-12 IN2007CH05103A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20801700P 2000-05-26 2000-05-26

Publications (1)

Publication Number Publication Date
IN2007CH05103A true IN2007CH05103A (en) 2008-08-27

Family

ID=22772880

Family Applications (2)

Application Number Title Priority Date Filing Date
IN2089CH2002 IN2002CH02089A (en) 2000-05-26 2002-12-16
IN5103CH2007 IN2007CH05103A (en) 2000-05-26 2007-11-12

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IN2089CH2002 IN2002CH02089A (en) 2000-05-26 2002-12-16

Country Status (48)

Country Link
EP (1) EP1296951B1 (en)
JP (2) JP3665053B2 (en)
KR (1) KR100757699B1 (en)
CN (1) CN1227233C (en)
AR (1) AR028577A1 (en)
AT (1) ATE483687T1 (en)
AU (2) AU2001264804B2 (en)
BG (1) BG65855B1 (en)
BR (1) BRPI0111140B8 (en)
CA (1) CA2410234C (en)
CR (1) CR6606A (en)
CY (1) CY1111440T1 (en)
CZ (1) CZ20023888A3 (en)
DE (1) DE60143197D1 (en)
DK (1) DK1296951T3 (en)
EA (1) EA004809B1 (en)
EE (1) EE05242B1 (en)
EG (1) EG24189A (en)
ES (1) ES2351958T3 (en)
GC (1) GC0000362A (en)
GE (1) GEP20053492B (en)
GT (1) GT200100091A (en)
HN (1) HN2001000110A (en)
HR (1) HRP20020934B1 (en)
HU (1) HU228423B1 (en)
IL (1) IL152582A0 (en)
IN (2) IN2002CH02089A (en)
IS (1) IS2806B (en)
JO (1) JO2216B1 (en)
MA (1) MA26919A1 (en)
ME (1) ME00428B (en)
MX (1) MX230696B (en)
MY (1) MY123569A (en)
NO (1) NO324495B1 (en)
NZ (1) NZ522394A (en)
PA (1) PA8516901A1 (en)
PE (1) PE20011324A1 (en)
PH (1) PH12001001175B1 (en)
PL (1) PL358153A1 (en)
PT (1) PT1296951E (en)
RS (1) RS51541B (en)
SI (1) SI1296951T1 (en)
SK (1) SK287174B6 (en)
SV (1) SV2002000462A (en)
TW (1) TWI303634B (en)
UA (1) UA73355C2 (en)
WO (1) WO2001092230A1 (en)
ZA (1) ZA200209558B (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6858631B1 (en) 1999-11-29 2005-02-22 Merck & Co., Inc. Polymorphic, amorphous and hydrated forms of 5-chloro-3-(4-methanesulfonylphenyl)-6′-methyl-[2,3′]bipyridinyl
EP1248618B1 (en) * 1999-11-29 2006-03-22 Merck Frosst Canada Inc. Polymorphic, amorphous and hydrated forms of 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- 2,3']bipyridinyl
US6521642B2 (en) * 2000-05-26 2003-02-18 Merck & Co., Inc. 5-chloro-3-(4-methanesulfonylphenyl)-6′-methyl-[2,3′]bipyridinyl in pure crystalline form and process for synthesis
HUE028730T2 (en) 2009-02-27 2017-01-30 Cadila Healthcare Ltd A process for the preparation of etoricoxib
WO2012004677A1 (en) 2010-07-05 2012-01-12 Actavis Group Ptc Ehf Solid state forms of etoricoxib salts
PL2714676T3 (en) 2011-05-27 2019-10-31 Farma Grs D O O A process for the preparation of polymorphic form i of etoricoxib
WO2013105106A1 (en) 2011-11-03 2013-07-18 Cadila Healthcare Limited An improved process for the preparation of etoricoxib and polymorphs thereof
WO2013075732A1 (en) 2011-11-21 2013-05-30 Synthon Bv Process for making crystalline form i of etoricoxib
EP2601952A1 (en) 2011-12-07 2013-06-12 Zentiva, k.s. Novel pharmaceutically acceptable salts and cocrystals of 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,3']bipyridinyl and their therapeutic uses
HUE033525T2 (en) 2012-08-27 2017-12-28 Cadila Healthcare Ltd Pharmaceutical compositions of etoricoxib
EP2888231B1 (en) 2012-08-27 2019-01-09 Glenmark Pharmaceuticals Limited Process for preparation of crystalline etoricoxib
CN104418799A (en) * 2013-09-03 2015-03-18 天津药物研究院 Etoricoxib crystal as well as preparation method and application thereof
WO2015036550A1 (en) 2013-09-13 2015-03-19 Synthon B.V. Process for making etoricoxib
CN106632003B (en) * 2015-12-31 2019-02-12 上海博志研新药物技术有限公司 A kind of preparation method of Etoricoxib
CN108069896B (en) * 2016-11-11 2022-08-12 昆明积大制药股份有限公司 Preparation method of etoricoxib crystal form
CN107056691B (en) * 2017-06-21 2020-03-10 四川尚锐生物医药有限公司 Method for preparing etoricoxib crystal form V
CN107417599B (en) * 2017-06-21 2020-06-09 四川尚锐生物医药有限公司 Preparation method of etoricoxib crystal form
MX2017009660A (en) 2017-07-26 2017-11-23 Laboratorios Liomont S A De C V Pharmaceutical composition with a range of ratio between tramadol chlorhydrate and etoricoxib for its administration for the treatment of pain.
CN107556231A (en) * 2017-09-23 2018-01-09 江苏正大清江制药有限公司 The crystal formation and preparation method for the salt that a kind of Etoricoxib is formed with paranitrobenzoic acid
CN107417600A (en) * 2017-09-26 2017-12-01 江苏正大清江制药有限公司 A kind of Etoricoxib and the novel crystal forms and preparation method of furancarboxylic acid forming salt
CN107898787B (en) * 2017-12-15 2018-11-30 扬子江药业集团上海海尼药业有限公司 A kind of pharmaceutical composition and its preparation and preparation method
MX2018013070A (en) 2017-12-29 2019-10-15 Gruenenthal Gmbh Pharmaceutical combination comprising extended-release tramadol hydrochloride and immediate-release etoricoxib, and its use for the treatment of pain.
CN110143915A (en) * 2019-06-03 2019-08-20 蚌埠学院 A new crystal form of etoricoxib and p-toluenesulfonic acid salt and preparation method

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593994A (en) * 1994-09-29 1997-01-14 The Dupont Merck Pharmaceutical Company Prostaglandin synthase inhibitors
US5739166A (en) * 1994-11-29 1998-04-14 G.D. Searle & Co. Substituted terphenyl compounds for the treatment of inflammation
US5861419A (en) * 1996-07-18 1999-01-19 Merck Frosst Canad, Inc. Substituted pyridines as selective cyclooxygenase-2 inhibitors
KR100371620B1 (en) * 1996-07-18 2003-05-09 머크 프로스트 캐나다 앤드 캄파니 Substituted pyridines as selective cyclooxygenase-2 inhibitors
PL193248B1 (en) * 1998-04-24 2007-01-31 Merck & Co Inc Process for synthesizing cox-2 inhibitors
EP1248618B1 (en) * 1999-11-29 2006-03-22 Merck Frosst Canada Inc. Polymorphic, amorphous and hydrated forms of 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- 2,3']bipyridinyl

Also Published As

Publication number Publication date
ZA200209558B (en) 2003-10-28
MXPA02011619A (en) 2003-03-27
BRPI0111140B8 (en) 2021-05-25
DE60143197D1 (en) 2010-11-18
KR20030003762A (en) 2003-01-10
SK16702002A3 (en) 2003-05-02
GC0000362A (en) 2007-03-31
BG65855B1 (en) 2010-03-31
EA200201264A1 (en) 2003-04-24
MY123569A (en) 2006-05-31
WO2001092230A1 (en) 2001-12-06
JP4142621B2 (en) 2008-09-03
IN2002CH02089A (en) 2005-02-25
BR0111140A (en) 2005-01-11
PT1296951E (en) 2010-12-07
AR028577A1 (en) 2003-05-14
CA2410234A1 (en) 2001-12-06
HUP0302336A2 (en) 2003-11-28
PA8516901A1 (en) 2002-04-25
IS6630A (en) 2002-11-20
EP1296951B1 (en) 2010-10-06
PH12001001175B1 (en) 2006-08-10
HRP20020934A2 (en) 2005-02-28
NO20025674L (en) 2002-11-26
BRPI0111140B1 (en) 2018-03-13
TWI303634B (en) 2008-12-01
IL152582A0 (en) 2003-05-29
HN2001000110A (en) 2002-03-06
EE200200655A (en) 2004-08-16
EP1296951A1 (en) 2003-04-02
JP2005047927A (en) 2005-02-24
AU6480401A (en) 2001-12-11
JP3665053B2 (en) 2005-06-29
EA004809B1 (en) 2004-08-26
IS2806B (en) 2012-09-15
CZ20023888A3 (en) 2003-02-12
AU2001264804B2 (en) 2006-04-06
SV2002000462A (en) 2002-03-08
EE05242B1 (en) 2009-12-15
MA26919A1 (en) 2004-12-20
UA73355C2 (en) 2005-07-15
CA2410234C (en) 2008-05-13
KR100757699B1 (en) 2007-09-13
SK287174B6 (en) 2010-02-08
CR6606A (en) 2006-02-06
BG107237A (en) 2003-05-30
HU228423B1 (en) 2013-03-28
ATE483687T1 (en) 2010-10-15
YU89402A (en) 2005-11-28
JO2216B1 (en) 2004-10-07
HK1058932A1 (en) 2004-06-11
ES2351958T3 (en) 2011-02-14
NO20025674D0 (en) 2002-11-26
GEP20053492B (en) 2005-04-25
MX230696B (en) 2005-09-19
NO324495B1 (en) 2007-10-29
PE20011324A1 (en) 2002-01-28
EG24189A (en) 2008-10-08
ME00428B (en) 2011-10-10
SI1296951T1 (en) 2011-01-31
HRP20020934B1 (en) 2012-01-31
PL358153A1 (en) 2004-08-09
GT200100091A (en) 2001-12-28
RS51541B (en) 2011-06-30
DK1296951T3 (en) 2011-01-24
CN1227233C (en) 2005-11-16
CY1111440T1 (en) 2015-08-05
NZ522394A (en) 2004-05-28
CN1443168A (en) 2003-09-17
JP2004501116A (en) 2004-01-15

Similar Documents

Publication Publication Date Title
BE2016C018I2 (en)
BE2013C048I2 (en)
BE2012C016I2 (en)
BE2011C032I2 (en)
BE2010C018I2 (en)
BRPI0113085B8 (en)
BRPI0110940B8 (en)
IN2002CH02089A (en)
JP2002036679A5 (en)
CH694022C1 (en)
BR0112866A2 (en)
CN300955183S (zh) 连接件
BRPI0000763B8 (en)
CN3134731S (en)
CN3144126S (en)
AU2000280319A8 (en)
AU2000278679A8 (en)
BY6855C1 (en)
AU2000267632A8 (en)
CL2001002979A1 (en)
AU2000264849A8 (en)
CN3133951S (en)
CN3134542S (en)
CN3148468S (en)
CN3135513S (en)